Skip to main content
. 2020 Oct 21;32(1):e1. doi: 10.3802/jgo.2021.32.e1

Fig. 2. Univariate survival analysis of the prognostic impact of a high pre-treatment SII on OS in patients with vulvar cancer depicted by a Kaplan-Meier curve. A high pre-treatment SII (>866.4) was associated with impaired OS translating to 3-year OS rates of 71.1% and 54.1% (p=0.001).

Fig. 2

OS, overall survival; SII, systemic immune-inflammation index.